A vaccine designed to ward off genital herpes has failed in a large clinical trial, abruptly ending the product's seemingly promising future.
No takes yet. Share an insight, caveat, or question.
Jon D. Cohen (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: